Frontiers in Public Health (Nov 2022)

Association between mortality and cardiovascular diseases in the vulnerable Mexican population: A cross-sectional retrospective study of the COVID-19 pandemic

  • Gerardo R. Padilla-Rivas,
  • Juan Luis Delgado-Gallegos,
  • Gerardo Garza-Treviño,
  • Kame A. Galan-Huerta,
  • Zuca G-Buentello,
  • Jorge A. Roacho-Pérez,
  • Michelle Giovana Santoyo-Suarez,
  • Hector Franco-Villareal,
  • Ahidée Leyva-Lopez,
  • Ana E. Estrada-Rodriguez,
  • Jorge E. Moreno-Cuevas,
  • Javier Ramos-Jimenez,
  • Ana M. Rivas-Estrilla,
  • Elsa N. Garza-Treviño,
  • Jose Francisco Islas

DOI
https://doi.org/10.3389/fpubh.2022.1008565
Journal volume & issue
Vol. 10

Abstract

Read online

Cardiovascular diseases (CVDs) continue to be the leading cause of death worldwide. Over the past couple of years and with the surge of the COVID-19 pandemic, mortality from CVDs has been slightly overshadowed by those due to COVID-19, although it was during the peak of the pandemic. In the present study, patients with CVDs (CVDs; n = 41,883) were analyzed to determine which comorbidities had the largest impact on overall patient mortality due to their association with both diseases (n = 3,637). Obesity, hypertension, and diabetes worsen health in patients diagnosed positive for COVID-19. Hence, they were included in the overview of all patients with CVD. Our findings showed that 1,697 deaths were attributable to diabetes (p < 0.001) and 987 deaths to obesity (p < 0.001). Lastly, 2,499 deaths were attributable to hypertension (p < 0.001). Using logistic regression modeling, we found that diabetes (OR: 1.744, p < 0.001) and hypertension (OR: 2.179, p < 0.001) significantly affected the mortality rate of patients. Hence, having a CVD diagnosis, with hypertension and/or diabetes, seems to increase the likelihood of complications, leading to death in patients diagnosed positive for COVID-19.

Keywords